News

Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration

ISELIN, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch…

2 years ago

ADVANCED MEDTECH EXPANDS LEADERSHIP TEAM WITH APPOINTMENT OF GREG MILLER AS CHIEF FINANCIAL OFFICER

Singapore, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Advanced MedTech Holdings appoints US-based CFO with more than 35 years’ expertise in…

2 years ago

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein…

2 years ago

Alignment Healthcare to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

ORANGE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced…

2 years ago

Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health

Latest NeuroStar innovation to simplify the motor threshold determination for cliniciansMALVERN, Pa., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc.…

2 years ago

Galecto Announces Publication Supporting the Predictive Role of Galectin-3 on Overall Survival of NSCLC Patients in Peer-Reviewed Scientific Journal

BOSTON, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development…

2 years ago

Avricore Health Reports Second-Quarter 2022 Results

VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased…

2 years ago

ALR Technologies Announces Update on the GluCurve Pet CGM Distribution and Commercialization

SINGAPORE, Aug. 29, 2022 (GLOBE NEWSWIRE) -- ALR Technologies SG Pte. Ltd (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes…

2 years ago

New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers

-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and…

2 years ago

Lowell Farms Inc. Announces Sale of Additional $2.2 Million of Convertible Debentures

SALINAS, Calif., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born innovator…

2 years ago